Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Tallac Therapeutics Appoints Kevin N. Heller, M.D., as Chief Medical Officer
Tallac Therapeutics, a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity […]
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company focused on therapies for cardiometabolic diseases, today announced that it […]
Asieris Appoints Dr. Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
Optibrium Appoints Steve Yemm as Chief Commercial Officer
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs
Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
Full-Life Technologies has announced the appointments of Steffen Heeger, MD, PhD, as Chief Medical Officer […]
Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors
Relmada Therapeutics, a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today […]
Novotech Acquires European CRO EastHORN, Strengthens Global Operations
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory […]
Quanterix Announces Appointment of Brian Blaser to Board of Directors
Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it […]
Novavax Names John C. Jacobs as New President & Chief Executive Officer
Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more